Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Comparing ETFs and mutual funds for retirement reveals tax efficiency differences driven by turnover, distributions, and account placement.
28,114 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
A prominent smart-money investor boosted bets on Intel as the AI-driven semiconductor rally intensifies. The rest of ...
As micron's earnings report almost arrives, investors weigh whether the AI memory boom can sustain MU's meteoric run....
A surprising all-stock deal sent ON Semiconductor lower, wiping out gains from a strong AI data center narrative. Her...
When a famous moment goes public, it isn’t just style—and it isn’t just drama. It reveals practical money lessons abo...
Lumentum’s fiery stock rally this year has propelled the optics company into the top tier of the market, signaling a ...
XRP is testing a breakout near $1.50 as institutional inflows and rising derivatives support a bullish setup. But a m...
When authorities in Italy halted two high-profile concerts, fans and promoters faced more than disappointment. This g...
The Pennsylvania House approved HB 2186, a by-right ADU reform, in a bipartisan vote and sent the bill to the Senate....
When a legendary investor hands the reins, the next era often comes with bolder bets. This article examines berkshire...
A JPMorgan-led projection suggests about $165 billion in stock sales could hit markets as major funds rebalance portf...
Bitcoin weakness pushes STRC to new lows as strategy's Saylor acknowledges 'volatility' as a real market test. This g...